NCT06142071

Brief Summary

The main questions the study aims to answer are:

  1. 1.The proportion of family members of cancer patients who say they need more support
  2. 2.What support family members feel would be beneficial

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 26, 2023

Completed
26 days until next milestone

First Posted

Study publicly available on registry

November 21, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

January 8, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2024

Completed
Last Updated

July 17, 2024

Status Verified

July 1, 2024

Enrollment Period

8 months

First QC Date

October 26, 2023

Last Update Submit

July 16, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • The proportion of family members who state they need more support

    The proportion of family members who state they need more support

    6 months after start of study recruitment

Secondary Outcomes (2)

  • The proportion of family members who state they need more support with each of the Carer Support Needs Assessment Tool (CSNAT) domains

    6 months after start of study recruitment

  • Types of additional support that family members feel would be beneficial as identified via the telephone questionnaires and interviews

    6 months after start of study recruitment

Interventions

Telephone questionnaire, which includes questions on participant's demographics, anxiety/depression scores, what support they find helpful and what additional support they feel would be beneficial

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Oncology patients in South West Wales, United Kingdom

You may qualify if:

  • diagnosed with a solid organ malignancy under the care of the oncology team
  • able to identify at least one family member who may be willing to participate in the study
  • \- a family member of a patient diagnosed with a solid organ malignancy under the care of the oncology team

You may not qualify if:

  • medical or psychiatric condition impairing ability to consent
  • the patient's treating oncologist's opinion is that participating in the study would cause severe distress to the patient or their family

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

South West Wales Cancer Centre

Swansea, United Kingdom

Location

MeSH Terms

Conditions

Neoplasms

Study Officials

  • Sing Yu Moorcraft

    Swansea Bay University Health Board

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 26, 2023

First Posted

November 21, 2023

Study Start

January 8, 2024

Primary Completion

September 1, 2024

Study Completion

September 1, 2024

Last Updated

July 17, 2024

Record last verified: 2024-07

Locations